Further to this, the inhibition of repulsive guidance molecule-a, an axon guidance gene that prevents axon growth and immune regulation, has shown therapeutic efficacy in MS animal models [29]. This evidence concerns the gene ENSG00000280371 and myeloid sarcoma.